Platform
Company
Microbiology & Infection
Review status
Currently under review
Pending specialist review and validation.
This blood test measures IgG antibodies that your immune system makes against Aspergillus fumigatus, a common mold found in soil, dust, and indoor environments. IgG antibodies reflect past or ongoing exposure and tend to persist, which helps clinicians assess longer-term interactions between you and this mold.
Clinicians use this test alongside your symptoms, chest imaging, and other laboratory studies to evaluate conditions such as chronic lung colonization or infection and certain allergic lung diseases related to Aspergillus. The result on its own does not diagnose or rule out disease, so it is interpreted in context.
Results can support the diagnosis of chronic pulmonary aspergillosis, aspergilloma, or hypersensitivity-related conditions when your clinical picture and imaging fit. Tracking antibody levels over time, ideally using the same method, may help monitor response to treatment and stability of disease.
Your clinician may order this test if you have a long-lasting cough, breathlessness, fatigue, coughing up blood, or lung cavities or nodules on scans, especially if you have underlying lung disease. It is often paired with tests such as Aspergillus IgE, galactomannan, fungal cultures, and high-resolution CT to provide a clearer picture.
A higher antibody level suggests your immune system has recognized Aspergillus fumigatus and may support a diagnosis when combined with your symptoms, examination, and imaging. Some people with frequent environmental exposure can have detectable antibodies without active illness, so results are weighed against other findings.
If you take medicines that suppress the immune system or have conditions that weaken immunity, you might not produce typical amounts of antibody. In that case, a low result does not fully exclude disease. When results are unexpected, your clinician may repeat the test, use the same laboratory for follow-up, or add other tests and imaging before deciding on next steps.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Treatment with antifungal drugs can reduce fungal burden and may gradually lower antibody levels, so timing relative to therapy can influence results and trends.
Transplant medicines, chemotherapy, high-dose steroids, and advanced HIV can blunt antibody production, leading to lower-than-expected values even when disease is present.
Different laboratories and methods use different calibrators and cutoffs, so absolute values are not interchangeable. Use the same lab for repeat testing to follow trends reliably.
Frequent exposure to mold in work or home environments can stimulate antibodies without active lung disease, which can contribute to a positive result.
Conditions like prior tuberculosis, COPD, bronchiectasis, or lung cavities increase the risk of chronic Aspergillus disease and can influence how results are interpreted.
Intravenous immunoglobulin and plasma products can passively transfer antibodies, occasionally causing transient false-positive results.
Severely hemolyzed or lipemic samples may affect assay performance. Collecting samples when you are clinically stable helps with comparison over time.
People with these conditions often have recurrent exposure to Aspergillus, so antibodies may be present. Results should be interpreted together with symptoms and imaging.
References